Study of Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inclisiran in Chinese Participants With Elevated Serum LDL-C
Clinical trial NCT04774003 · COMPLETED
Trial details
- NCT number
- NCT04774003
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-26
- Primary completion
- 2021-10-18
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.